Hearing News Watch

Featured image for “Landmark Gene Therapy Clinical Trial Aims to Restore Hearing in Children with Genetic Hearing Loss”
Oct. 13, 2023

Landmark Gene Therapy Clinical Trial Aims to Restore Hearing in Children with Genetic Hearing Loss

HHTM
CAMBRIDGE, ENGLAND — Addenbrooke’s Hospital in Cambridge is part of an landmark global trial that seeks to restore hearing in children with a rare genetic condition. The trial is exploring the potential of gene therapy to restore hearing in children with severe to profound hearing loss due to auditory neuropathy, a condition that disrupts nerve impulses from the inner ear
Featured image for “HearUSA Expands Hearing Care Access with Two New Hearing Centers of the Future in Texas”
Oct. 11, 2023

HearUSA Expands Hearing Care Access with Two New Hearing Centers of the Future in Texas

HHTM
HOUSTON, TEXAS — HearUSA has opened two new Hearing Centers in Tomball and Atascocita, Texas. As part of their ongoing initiative to roll out Hearing Centers of the Future across the United States, these new facilities provide support for the approximately 48 million Americans facing hearing loss. At the Tomball and Atascocita centers, clients can explore a range of prescription
Featured image for “U.S. Army Funds Research on Sound Sensitivity in Autism Spectrum Disorder”
Oct. 10, 2023

U.S. Army Funds Research on Sound Sensitivity in Autism Spectrum Disorder

HHTM
DALLAS, TEXAS — A University of Texas at Dallas auditory neuroscientist, Dr. Kelly Jahn, is set to receive an $850,000 grant from the U.S. Army Medical Research and Development Command to investigate why individuals with autism spectrum disorder (ASD) often exhibit heightened sensitivity to sound, a condition known as hyperacusis. Dr. Jahn’s research aims to uncover biomarkers for hyperacusis, potentially
Featured image for “Acousia Therapeutics Receives Approval for Phase 2 Clinical Trial Addressing Cisplatin-Induced Hearing Loss”
Oct. 09, 2023

Acousia Therapeutics Receives Approval for Phase 2 Clinical Trial Addressing Cisplatin-Induced Hearing Loss

HHTM
TÜBINGEN, GERMANY – Acousia Therapeutics, a clinical-stage biotech company specializing in innovative drug therapies for hearing loss, has obtained regulatory approval from the German regulatory authorities (BfArM) for its Phase 2 clinical trial of the etiology-agnostic otoprotectant ACOU085 in patients with cisplatin-induced hearing loss. Chemotherapy and Hearing Loss Cisplatin-based chemotherapy, a vital treatment for many cancer patients, often results in an
Featured image for “Teleaudiology Today: New Book Explores the Future of Hearing Care in the Digital Age”
Oct. 09, 2023

Teleaudiology Today: New Book Explores the Future of Hearing Care in the Digital Age

HHTM
The concept of telehealth, which involves providing healthcare services through remote technology, has brought about a significant transformation in patient care. Although the idea of telehealth has existed for decades, it has only recently become a fundamental pillar of modern healthcare. In the field of audiology, innovative tools like remote otoscopy, remote audiometry, and remotely adjustable hearing aids have emerged.
Featured image for “University of Basel Scientists Identify Key Pathway in Age-Related Hearing Decline”
Oct. 06, 2023

University of Basel Scientists Identify Key Pathway in Age-Related Hearing Decline

HHTM
BASEL, SWITZERLAND — Although current approaches to hearing loss management primarily involve hearing aids or, in some instances, cochlear implants, researchers at the University of Basel are advancing our understanding of hearing loss mechanisms. “In order to develop new therapies, we need to better understand what the auditory sensory cells need for proper function” –Dr. Maurizio Cortada, Dept. of Biomedicine
Featured image for “ADA Announces Board of Directors Election Results: Drs. Amlani, Davis, and O’Brien Elected to Serve”
Oct. 04, 2023

ADA Announces Board of Directors Election Results: Drs. Amlani, Davis, and O’Brien Elected to Serve

HHTM
FRANKFORT, KENTUCKY — The Academy of Doctors of Audiology (ADA) has announced the election results for the organization’s Board of Directors. Amyn Amlani, Ph.D. has been elected to serve as ADA President-Elect for the 2024 program year. Dr. Amlani is the President of Otolithic, LLC—a for-profit firm with its global headquarters in Frisco, TX—that provides healthcare companies with competitive market analysis and support
Featured image for “Starkey Executives Brandon Sawalich and Achin Bhowmik Clinch Gold for Leadership Excellence in 2023 Globee Awards”
Oct. 04, 2023

Starkey Executives Brandon Sawalich and Achin Bhowmik Clinch Gold for Leadership Excellence in 2023 Globee Awards

HHTM
EDEN PRAIRIE, MINNESOTA – Starkey has announced that two of its executives have been named Gold Award winners in the 2023 Globee Awards for Leadership. Brandon Sawalich, President and CEO at Starkey, won Gold in the Executive Excellence of the Year in Manufacturing category, and Achin Bhowmik, Ph.D., Chief Technology Officer and Executive Vice President of Engineering at Starkey, was named the Most Innovative
Featured image for “Starkey Hosts Exclusive Global Artificial Intelligence Hearing Health Summit”
Oct. 02, 2023

Starkey Hosts Exclusive Global Artificial Intelligence Hearing Health Summit

HHTM
EDEN PRAIRIE, MINNESOTA – Starkey hosted an exclusive, global Artificial Intelligence (AI) Hearing Health Summit featuring experts and visionaries in the AI and hearing healthcare space, including Apple, Google, MIT, and Stanford. At this exclusive, first-of-its-kind Summit, attendees had the opportunity to meet the minds behind Starkey’s ground-breaking hearing innovations, hear from global innovation leaders, and get a behind-the-scenes look
Featured image for “WS Audiology Announces Appointment of Joerg Brandscheid as New Chief Technology Officer”
Oct. 02, 2023

WS Audiology Announces Appointment of Joerg Brandscheid as New Chief Technology Officer

HHTM
LYNGE, DENMARK – WS Audiology (WSA) announced the appointment today of Joerg Brandscheid as its Chief Technology Officer (CTO) and a member of the Executive Committee. Brandscheid is set to join the WSA team on November 1, 2023, following the completion of his current role as CTO at Polestar, Sweden’s renowned electric performance car brand. Brandscheid brings a wealth of